Analysis of immune regulatory genes in familial and sporadic graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4562-4568

  Ban, Yoshiyuki ^a   Concepcion, Erlinda S ^a   Villanueva, Ronald ^a   Greenberg, David A ^b   Davies, Terry F ^a   Tomer, Yaron ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR3 ANTIGEN;

ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE FREQUENCY; GENE INTERACTION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; PRIORITY JOURNAL; REGULATOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; GRAVES DISEASE; HLA-DR3 ANTIGEN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROIDITIS, AUTOIMMUNE;

EID: 4544336642     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031693     Document Type: Article

References (45)

1. 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499
2. Davies TF 2000 Graves' diseases: pathogenesis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkins; 518-530
3. Tomer Y, Davies TF 1993 Infection, thyroid disease and autoimmunity. Endocr Rev 14:107-120
4. Matos-Santos A, Nobre EL, Costa JGE, Nogueira PJ, Macedo A, Galvao-Teles A, de Castro J 2003 Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre. Clin Endocrinol (Oxf) 55:15-19
5. Tomer Y, Davies TF 2003 Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24:694-717
6. Villanueva R, Greenberg DA, Davies TF, Tomer Y 2003 Sibling recurrence risk in autoimmune thyroid disease. Thyroid 13:761-764
7. Farid NR 1981 Graves' disease. In: Farid NR, ed. HLA in endocrine and metabolic disorders. New York: Academic Press; 85-143
8. Mangklabruks A, Cox N, DeGroot LJ 1991 Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 73:236-244
9. Farid NR, Stone E, Johnson G 1980 Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf) 13:535-544
10. Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, Dodson PM, Sheppard MC, Barnett AH, Franklyn JA, Gough SC 1998 Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 83:3394-3397
11. Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ 2000 Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet 95:432-437
12. Bode HH, Dorf ME, Forbes AP 1973 Familial lymphocytic thyroiditis: analysis of linkage with histocompatibility and blood group. J Clin Endocrinol Metab 37:692-697
13. Roman SH, Greenberg DA, Rubinstein P, Wallenstein S, Davies TF 1992 Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 74:496-503
14. Shields DC, Ratanachaiyavong S, McGregor AM, Collins A, Morton NE 1994 Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am J Hum Genet 55:540-554
15. Hawkins BR, Ma JT, Lam KS, Wang CC, Yeung RT 1985 Analysis of linkage between HLA haplotype and susceptibility to Graves' disease in multiple-case Chinese families in Hong Kong. Acta Endocrinol (Copenh) 110:66-69
16. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T 2001 Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 10:1379-1386
17. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF 2003 Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736-747
18. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH 1999 The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 8:1195-1199
19. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ 1995 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80:41-45
20. Kotsa K, Watson PF, Weetman AP 1997 A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 46:551-554
21. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA 1996 The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5:1075-1080
22. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K 1997 CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146
23. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC 1999 The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 84:2398-2401
24. Villanueva RB, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, Maclaren N, Sun ZS, Zhang DM, Tucci S, Davies TF 2000 Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 and evidence for an environmental etiology. Thyroid 10:791-798
25. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW 2000 Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10:851-858
26. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K 1998 CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51:563-566
27. Tomer Y, Greenberg DA, Barbesino G, Concepcion ES, Davies TF 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86:1687-1693
28. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y 2003 Analysis of the CTLA-4, CD28 and inducible co-stimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 4:586-593
29. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Geneva G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511
30. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI 2002 Nomenclature for factors of the HLA system, 2002. Hum Immunol 63:1213-1268
31. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y 2002 The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 57:81-88
32. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SH 1999 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 354:743-744 (Letter)
33. Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, Jussiff JM, Fisk GJ, Miller CP, Collins M 2001 Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics 78:155-168
34. Woolf B 1955 On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253
35. Brix TH, Christensen K, Holm NV, Harvald B, Hegedus L 1998 A population-based study of Graves' diseases in Danish twins. Clin Endocrinol (Oxf) 48:397-400
36. Brix TH, Kyvik KO, Christensen K, Hegedus L 2001 Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86:930-934
37. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, McDermott M, Sinha AA, Timmerman L, Steinman L 1988 A molecular basis for MHC class II-associated autoimmunity. Science 240:1003-1009
38. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y 2004 Arginine at position 74 of the HLA-DRβ1 chain is associated with Graves' disease. Genes Immun 5:203-208
39. Tomer Y 2001 Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid 11:167-169
40. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA 1999 ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397:263-266
41. Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S, Nguyen T, Burwell T, Schneider H, Gonzalo JA, Gosselin M, Owen LR, Rudd CE, Gutierrez-Ramos JC 2000 The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13:95-105
42. Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K 1997 Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 82:4130-4132
43. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T 1997 CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7:843-846
44. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, Cho BY 2000 Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10:453-459
45. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1999 Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84:4656-4664